Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.linkpharmachem.co.in | |
Market Cap | 24.02 Cr. | |
Enterprise Value(EV) | 30.98 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 3.71 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 14.58 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 30.86 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 34.14 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.58 | Calculated using Price: 54.10 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.44 Cr. | 4,440,568 Shares |
FaceValue | 10 | |
Company Profile | ||
Link Pharma Chem, incorporated on December 28, 1984 is a manufacturer of thionyl chloride. |
1 Day |
|
+0.72% |
1 Week |
|
+3.14% |
1 Month |
|
-0.18% |
3 Month |
|
+33.10% |
6 Month |
|
+22.45% |
1 Year |
|
+12.59% |
2 Year |
|
+95.80% |
5 Year |
|
+34.38% |
10 Year |
|
+712.50% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 4.97 | -23.07 | 6.83 | 2.58 | 12.34 | 6.53 | 8.71 | 9.04 | 13.92 | |
Return on Capital Employed (%) | 9.32 | -8.74 | 9.83 | 9.26 | 15.38 | 10.31 | 12.87 | 13.58 | 16.57 | |
Return on Assets (%) | 2.01 | -8.35 | 2.70 | 1.31 | 6.61 | 3.74 | 5.14 | 4.82 | 6.84 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 11 | 8 | 9 | 9 | 10 | 10 | 11 | 13 | 14 | 15 | |
Non Curr. Liab. | 6 | 8 | 1 | 2 | 3 | 3 | 4 | 4 | 4 | 3 | |
Curr. Liab. | 10 | 9 | 7 | 7 | 4 | 5 | 3 | 9 | 11 | 12 | |
Minority Int. | |||||||||||
Equity & Liab. | 26 | 26 | 18 | 17 | 17 | 18 | 19 | 26 | 29 | 31 | |
Non Curr. Assets | 17 | 18 | 10 | 10 | 11 | 11 | 10 | 11 | 15 | 15 | |
Curr. Assets | 10 | 8 | 7 | 7 | 7 | 7 | 9 | 15 | 14 | 15 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 26 | 26 | 18 | 17 | 17 | 18 | 19 | 26 | 29 | 31 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 24 | 18 | 12 | 16 | 24 | 25 | 25 | 35 | 54 | 45 | |
Other Income | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
Total Income | 24 | 18 | 15 | 16 | 24 | 25 | 26 | 35 | 54 | 46 | |
Total Expenditure | -21 | -18 | -13 | -14 | -21 | -22 | -23 | -32 | -50 | -42 | |
PBIDT | 3 | -1 | 3 | 2 | 3 | 2 | 3 | 3 | 4 | 4 | |
Interest | -1 | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | -1 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | |
Exceptional Items | |||||||||||
PAT | 1 | -2 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | |
Adjusted EPS | 1 | -5 | 1 | 1 | 3 | 1 | 2 | 2 | 4 | 4 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -1 | 1 | 5 | -4 | 2 | 4 | 1 | 3 | 5 | -1 | |
Cash Fr. Inv. | -1 | -1 | -3 | 9 | -1 | -1 | -1 | -2 | -2 | -5 | |
Cash Fr. Finan. | 2 | 0 | -1 | -6 | -1 | -3 | 0 | 1 | 0 | 2 | |
Net Change | 0 | 0 | 1 | -1 | 0 | 0 | 2 | 2 | -4 | ||
Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 4 | 0 |
Thu, 02 Feb 2023
Board Meeting Intimation for Intimation Of Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended December 31 2022. LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve Unaudited Financial Results for the quarter ended December 31 2022. |
Wed, 01 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. |
Mon, 16 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. |
Wed, 08 Feb 2023 |
|
|
|
|
|